#4-34E. Elevating Observational Evidence: The TARGET Statement for Trial Emulation (BMJ, 2025)

When randomized controlled trials (RCTs) are unfeasible or unavailable, how can clinicians reliably interpret causal inferences from observational data? The TARGET (Transparent Reporting of Observational Studies Emulating a Target Trial) Statement addresses this fundamental clinical challenge by providing the first consensus-based reporting guideline for observational studies that explicitly emulate a hypothetical pragmatic RCT. Developed through a rigorous EQUATOR framework process involving systematic reviews, expert surveys, and consensus meetings, the statement introduces a comprehensive 21-item checklist to enhance reporting transparency and quality. The most pivotal contribution of this research is the establishment of a standardized framework that systematically maps target trial protocols—such as eligibility criteria, treatment strategies, and causal contrasts—to observational data. However, when critically appraising studies using this tool, readers should note that the current guideline primarily focuses on parallel-group trial emulation with baseline confounding adjustment, and may not comprehensively cover all complex study designs or advanced analytical methods. For clinicians, the TARGET statement serves as an indispensable analytical tool; by evaluating whether observational studies strictly adhere to these reporting standards, physicians can more accurately appraise study validity, mitigate potential design-related biases, and confidently apply real-world evidence to optimize everyday patient care.

Citation: Cashin AG, McAuley JH, et al. Transparent reporting of observational studies emulating a target trial: the TARGET Statement. BMJ. 2025. DOI: 10.1136/bmj-2025-087179

Disclaimer: This audio summary is based on personal interpretation and does not guarantee the exact content of the original paper. Please refer to the original article for details.